Medtronic shares took off after the company posted better financial results than expected, boosted by what management called a “robust” volume of medical procedures.

Medtronic CTO Jim Peichel [Image from Peichel’s LinkedIn feed] Medtronic (NYSE: MDT) + has promoted the head of its Cardiac Implantables Technology Development Center to be its new chief technology ...

REDMOND, Wash., Nov. 19, 2025 /PRNewswire/ -- Vesiflo, Inc. today announced a major reimbursement milestone for its inFlow ™ Voiding Prosthesis, following the Centers for Medicare & Medicaid Services ...

Medtronic's cardiovascular sales rise 10.8% to $3.44 bln CEO emphasizes on cardiology and neuroscience M&A CFO confirms diabetes business to go public in 2026 Nov 18 (Reuters) - Medtronic (MDT.N), ...

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results, with sales hitting $8.96 billion, surpassing the consensus estimate of $8.87 billion. This marks a 6.6% increase ...

Minnesota medtech giant Medtronic found positive momentum Tuesday morning as it faced down what top executives see as a critical moment for the maker of innovative medical devices and procedures for ...

Medtronic’s pulsed field ablation business took off last quarter as competition in the space continues to heat up nearly two years after products first launched. PFA sales grew by more than 300% year ...

Medtronic officials today said the planned separation of its Diabetes business (MiniMed) remains on track, with future offerings also on the horizon. On the company’s second-quarter earnings call, CFO ...